News Daily News La Monoterapia con Aspirina Post-TAVR No es Menos Eficaz y es Posiblemente Más Segura que el Tratamiento Antiplaquetario Doble May 14, 2015
News Daily News Ticagrelor Suprime Más Rápidamente la Inhibición Plaquetaria que Clopidogrel en Pacientes SCA de Riesgo Bajo durante la realización de PCI Ad Hoc Todd Neale May 11, 2015
News Daily News Ticagrelor More Rapidly Suppresses Platelet Activity Than Clopidogrel for Low-Risk ACS Patients During Ad Hoc PCI Todd Neale May 11, 2015
Presentation Ticagrelor vs Clopidogrel in Troponin-Negative ACS Patients Undergoing Ad Hoc PCI Presenter: Roxana Mehran May 08, 2015
News Industry News Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients May 07, 2015
News Daily News El Tratamiento Antiplaquetario Doble se asoció a Mejores Resultados en Pacientes EAP de Alto Riesgo Leah Lawrence April 29, 2015
News Daily News Dual Antiplatelet Therapy Tied to Better Outcomes in High Risk PAD Patients Leah Lawrence April 29, 2015
News Daily News Meta-analyses Shed Light on the Impact of DAPT Duration Caitlin E. Cox April 03, 2015
Presentation ACC 2015 Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin Presenter: Marc S. Sabatine March 14, 2015
News Conference News ACC 2015 Long-Term DAPT with Ticagrelor Reduces Ischemic Risk, Ups Bleeding in MI Patients Todd Neale March 14, 2015
Presentation Economic Analysis of Ticagrelor TherapyFrom a US Perspective Presenter: Patricia A. Cowper February 02, 2015
News Daily News Long-term Ticagrelor Therapy Cost-Effective in US Patients L.A. McKeown February 02, 2015
News Daily News Un Análisis Conjunto a Nivel del Paciente Avala el Uso de Bivalirudina en PCI Primarias Yael L. Maxwell January 12, 2015
News Daily News Patient-Level Pooled Analysis Supports Bivalirudin Use in Primary PCI Yael L. Maxwell January 12, 2015
News Features Despite New Findings, Optimal DAPT Duration Still Up in the Air Todd Neale December 10, 2014
News Features A pesar de los Nuevos Hallazgos, la Duración Óptima del Tratamiento Antiplaquetario Doble Sigue en el Aire Todd Neale December 10, 2014
News Conference News AHA 2014 Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel Yael L. Maxwell November 17, 2014
Presentation TCT 2014 The Case for Selective Use of Prasugrel and Ticagrelor in PCI Patients with Stable CAD Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Matthew J. Price September 14, 2014